星洲熱股評析
私人领域及印尼业务向好．发马全年业绩有望达标
2017-05-18 09:17
发马2017财政年首季业绩符合预期，分析员相信纵然短期经营权业务将面对挑战，但私人领域及印尼业务表现向好将抵销利空，全年业绩达标料不成问题，维持财测不变。
（吉隆坡17日讯）发马（PHARMA，7081，主板贸服组）2017财政年首季业绩符合预期，分析员相信纵然短期经营权业务将面对挑战，但私人领域及印尼业务表现向好将抵销利空，全年业绩达标料不成问题，维持财测不变。
MIDF研究相信，政府尝试避免采购系统浪费的措施，将导致未来的药物及医药采购更为谨慎，可能使短期内经营权业务面临挑战，但值得欣慰的是，私人领域及印尼业务表现良好料烘托未来盈利贡献，相信公司可达到盈利目标。
肯纳格研究指出，出货量波动和营运开销增加可能拖累发马业绩，而医药信息系统（PHIS）也会拖累表现，幸而印尼业务增长和进军欧洲计划可能捎来惊喜。
该行认为，长期来看，发马制造业务表现可望恢复稳定，同时公司计划10年内增加200种新产品，将产品种类提高到500种，这也有望提振业务表现，因此给予“超越大市“评级，目标价调高至4令吉30仙。
文章来源：
星洲日报‧财经‧2017.05.18http://www.sinchew.com.my/node/1644132/%E7%A7%81%E4%BA%BA%E9%A2%86%E5%9F%9F%E5%8F%8A%E5%8D%B0%E5%B0%BC%E4%B8%9A%E5%8A%A1%E5%90%91%E5%A5%BD%EF%BC%8E%E5%8F%91%E9%A9%AC%E5%85%A8%E5%B9%B4%E4%B8%9A%E7%BB%A9%E6%9C%89%E6%9C%9B%E8%BE%BE%E6%A0%87
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
3,512.16%More articles on 星洲熱股評析
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Latest Videos
MQ Trading Signals
Time
Signal
Duration
Type
2024-11-26 15:00:00
TURTLE SYSTEM 20
30 Mins
SELL
2024-11-26 15:00:00
TURTLE SYSTEM 55
30 Mins
SELL
2024-11-26 15:00:00
TURTLE SYSTEM 20
10 Mins
SELL
2024-11-26 15:00:00
TURTLE SYSTEM 55
10 Mins
SELL
2024-11-26 15:00:00
TURTLE SYSTEM 20
Hourly
SELL
Apps
Top Articles
2
3
4
5
save malaysia!
6
THE INVESTMENT APPROACH OF CALVIN TAN
7
Koon Yew Yin's Blog
8
Good Articles to Share
Le Pen makes new threat to withdraw support for French government
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
